Search clinical trials for: A2: Etoricoxib

Total 330 results

Muhammad Ilyas

Not yet recruiting

The Effect of Pregabalin and Etoricoxib on Pain Alone Versus in Combination

Back Pain Lower Back Chronic
Organon and Co

Completed

A Study to Asses the Effect of MK0663 in the Treatment of Patients With Postoperative Dental Pain (0663-092)

Postoperative Dental Pain
Dexa Medica Group
PT. Equilab International

Completed

Bioequivalence Study of 120 mg Etoricoxib Film-coated Tablets

Healthy

Indonesia
University of Regensburg
ClinAssess GmbH

Unknown

Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma

Advanced Melanoma

Germany
James Felker
National Cancer Institute (NCI); Connor's Cure

Recruiting

A Vaccine Trial for Low Grade Gliomas

Low Grade Glioma

United States
Purdue University

Completed

Comparing the Digestion of Milk With Different Beta-casein Protein Content by Dairy Intolerant Persons

Dairy Intolerance

United States
Rambam Health Care Campus

Completed

Biomarkers for Prediction of Analgesic Efficacy in Knee OA.

Knee, Osteoarthritis (OA) | Biomarkers for Prediction of OA Treatment Efficacy

Israel
Asker & Baerum Hospital

Completed

COX-2 Inhibitor Versus Glucocorticoid Versus Both Combined

Rupture of Anterior Cruciate Ligament

Norway
Ophirex, Inc.

Recruiting

Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for Snakebite (BRAVIO) (BRAVIO)

Snakebite | Envenoming, Snake

United States
Organon and Co

Completed

Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1)

Dysmenorrhea
Oslo University Hospital

Completed

Rebound Pain After Operations for Distal Radius Fractures With a Volar Plate in Brachial Plexus Block

Pain, Postoperative | Brachial Plexus Block

Norway
Novartis Pharmaceuticals

Completed

Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer (INV342)

Prostate Cancer

Germany
University of Alabama at Birmingham
Astellas Scientific & Medical Affairs, Inc.

Completed

Heart Rate Response to Regadenoson and Sudden Cardiac Death

Sudden Cardiac Death | Left Ventricular Systolic Dysfunction

United States
Christine Lau, MD
National Heart, Lung, and Blood Institute (NHLBI)

Unknown

Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation

Lung Transplant

United States
Dana-Farber Cancer Institute
Johns Hopkins University; Washington University School of Medicine; National... and other collaborators

Completed

Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease

Sickle Cell Disease

United States
Gilead Sciences

Terminated

Stress Echocardiography Study With Regadenoson

Coronary Artery Disease | Heart Disease

United Kingdom
Dipan Shah
Astellas Pharma Global Development, Inc.

Unknown

Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease

Coronary Artery Disease

United States
University of Chicago
Astellas Pharma Inc

Completed

Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging

Coronary Disease

United States
Paul Kim

Recruiting

Allograft Dysfunction in Heart Transplant

Heart Transplant Failure and Rejection

United States
Timothy M. Bateman
Saint Luke's Health System; Saint Luke's Cardiovascular Consultants

Completed

Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging

Coronary Artery Disease

United States
Washington University School of Medicine
Astellas Pharma US, Inc.

Completed

Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson (PET/MR-P)

Ischemic Heart Disease

United States
Emory University

Withdrawn

Phase Analysis and Obstructive CAD on Rubidium PET

Coronary Artery Disease

United States
GE Healthcare
Covance

Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients (Rapiscan PIP)

Myocardial Ischemia | Coronary Artery Disease

France, Greece, Italy, United Kingdom
M.D. Anderson Cancer Center
Astellas Scientific & Medical Affairs, Inc.

Active, not recruiting

Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking

Ischemia

United States
University of Illinois at Chicago
Astellas Pharma Inc

Completed

Assessment of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements

Coronary Artery Disease

United States
Tatyasaheb Kore Dental College

Completed

EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDOMIZED CONTROLLED TRIAL (RCT).

Periodontitis | Saliva | Cyclooxygenase Two Inhibitors | Etoricoxib | Superoxide Dismutase

India
X-pert Med GmbH

Completed

Study of Etoricoxib for the Treatment of Muscle Pain and Inflammation Induced by Eccentric Exercise

Muscle Pain

Germany
Singapore General Hospital
Merck Sharp & Dohme LLC

Completed

Efficacy Study of Pre-emptive Etoricoxib for Postoperative Pain and Functional Outcome in Total Knee Arthroplasty

Knee Osteoarthritis

Singapore
Spanish Foundation of Rheumatology

Completed

Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs

Ankylosing Spondylitis

Spain
University of Regensburg
Merck Sharp & Dohme LLC

Completed

Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty

Coxarthrosis | Arthroplasties Hip Replacement | Perioperative Blood Loss

Germany
Barbro Dahlen
Karolinska Institutet

Completed

COX-2 Inhibition in Allergic Asthma

Asthma

Sweden
Ruhr University of Bochum

Terminated

Efficacy of Etoricoxib on Peripheral Hyperalgesia

Radiculopathy | Postherpetic Neuralgia | Causalgia | Peripheral Nerve Injury | Polyneuropathy

Germany
Cliniques universitaires Saint-Luc- Université...

Terminated

Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma

Metastatic Melanoma

Belgium
Astellas Pharma Inc

Completed

A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease

Coronary Artery Disease | Pulmonary Disease, Chronic Obstructive | Asthma

United States
Washington University School of Medicine
Astellas Pharma US, Inc.

Completed

Myocardial Perfusion Magnetic Resonance Imaging Using Regadenoson

Ischemic Heart Disease

United States
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin Pharma, Inc.

Completed

Effect of Mild Hepatic Impairment on the Pharmacokinetics of Istradefylline

Hepatic Impairment

United States
University of Maryland, Baltimore
Astellas Pharma US, Inc.

Completed

Maximal Bruce Protocol With the Use of Regadenoson For Myocardial Perfusion Stress Testing (Rega Stress)

Cardiac Function

United States
University of Chicago
Astellas Pharma Inc

Completed

Stress CT Perfusion in Patients With Chest Pain

Coronary Artery Disease

United States
University of Chicago
Astellas Pharma Inc

Completed

Stress Testing and Cardiac Magnetic Resonance

Coronary Disease

United States
Medical University of South Carolina
Astellas Pharma US, Inc.

Completed

Use of Lexiscan for Myocardial Stress Perfusion Computed Tomography With a 3rd Generation Dual Source CT System

Cardiovascular Diseases | Coronary Artery Disease

United States
University of Aarhus

Unknown

The Effect of A2A Adrenoceptor Stimulation on the Diameter of Retinal Arterioles During Hypoxia in Vivo

Retinal Artery Occlusion

Denmark
Kyowa Kirin, Inc.

Completed

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

Parkinson's Disease

United States
Timothy M. Bateman, MD

Completed

Characterization of Myocardial Blood Flow Measurements Using Lexiscan®™ (Regadenoson) (Lexiscan®™) Rubidium-82 Myocardial Perfusion PET: A Temporal-Dependency Investigation

Myocardial Blood Flow Reserve

United States
Guangdong Provincial Hospital of Traditional Chinese...

Recruiting

Immediate Analgesic Effects of Cheek Acupuncture for Acute Gouty Arthritis (CAAGA)

Acute Pain | Acupuncture | Acute Gout Arthritis

China
Organon and Co

Completed

Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)

Arthritis | Osteoarthritis | Rheumatoid Arthritis | Gout | Ankylosing Spondylitis
Virginia Commonwealth University
Kyowa Kirin, Inc.

Recruiting

Istradefylline for Parkinson Disease With Cognitive Impairment

Parkinson Disease | Cognitive Impairment

United States
Kyowa Kirin, Inc.
Kyowa Kirin Co., Ltd.

Completed

Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome

Sleep Disorder | Restless Legs Syndrome

United States
Kyowa Kirin Co., Ltd.

Completed

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease

Parkinson's Disease

Japan
Guangdong Provincial People's Hospital

Completed

Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib

Pain Syndrome

China
Analgesic Solutions
Merck Sharp & Dohme LLC

Unknown

Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain

Neuralgia | Postherpetic Neuralgia

United Kingdom

Search clinical trials for: A2: Etoricoxib

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations